BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15588742)

  • 1. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
    Domanski M; Antman EM; McKinlay S; Varshavsky S; Platonov P; Assmann SF; Norman J
    Control Clin Trials; 2004 Dec; 25(6):553-62. PubMed ID: 15588742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.
    Cooper HA; Domanski MJ; Rosenberg Y; Norman J; Scott JH; Assmann SF; McKinlay SM; Hochman JS; Antman EM;
    Am Heart J; 2004 Dec; 148(6):1012-9. PubMed ID: 15632887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
    Simes RJ; O'Connell RL; Aylward PE; Varshavsky S; Diaz R; Wilcox RG; Armstrong PW; Granger CB; French JK; Van de Werf F; Marschner IC; Califf R; White HD;
    Am Heart J; 2010 Jun; 159(6):988-97. PubMed ID: 20569711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
    Steinberg BA; Moghbeli N; Buros J; Ruda M; Parkhomenko A; Raju BS; GarcĂ­a-Castillo A; Janion M; Nicolau JC; Fox KA; Morrow DA; Gibson CM; Antman EM
    Am Heart J; 2007 Jul; 154(1):54-61. PubMed ID: 17584551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.
    Giugliano RP; Llevadot J; Wilcox RG; Gurfinkel EP; McCabe CH; Charlesworth A; Thompson SL; Antman EM; Braunwald E;
    Eur Heart J; 2001 Sep; 22(18):1702-15. PubMed ID: 11511120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Reed SD; McMurray JJ; Velazquez EJ; Schulman KA; Califf RM; Kober L; Maggioni AP; Van de Werf F; White HD; Diaz R; Mareev V; Murin J;
    Am Heart J; 2006 Sep; 152(3):500-8. PubMed ID: 16923421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
    Rogers WJ; Frederick PD; Stoehr E; Canto JG; Ornato JP; Gibson CM; Pollack CV; Gore JM; Chandra-Strobos N; Peterson ED; French WJ
    Am Heart J; 2008 Dec; 156(6):1026-34. PubMed ID: 19032996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
    Cantor WJ; Goodman SG; Cannon CP; Murphy SA; Charlesworth A; Braunwauld E; Langer A
    Am Heart J; 2005 Feb; 149(2):275-83. PubMed ID: 15846265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry (VENEto acute myocardial infarction REgistry].
    Di Pede F; Olivari Z; Schievano E; Spolaore P; Cacciavillani L; La Vecchia L; Bruni A; Zuin G; Franco GF; Palatini O; Morando G; Tinto M; Rossi M; Guarnerio M;
    Ital Heart J Suppl; 2005 Dec; 6(12):804-11. PubMed ID: 16444924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction.
    Fefer P; Hod H; Hammerman H; Boyko V; Behar S; Matetzky S;
    Am J Cardiol; 2009 Jan; 103(2):149-53. PubMed ID: 19121427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials.
    Wijeysundera HC; You JJ; Nallamothu BK; Krumholz HM; Cantor WJ; Ko DT
    Am Heart J; 2008 Sep; 156(3):564-572, 572.e1-2. PubMed ID: 18760142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial.
    Wong CK; Gao W; Stewart RA; French JK; Aylward PE; White HD
    Heart; 2009 Feb; 95(4):276-82. PubMed ID: 19074924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
    Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.